JP2017512058A5 - - Google Patents

Download PDF

Info

Publication number
JP2017512058A5
JP2017512058A5 JP2016553562A JP2016553562A JP2017512058A5 JP 2017512058 A5 JP2017512058 A5 JP 2017512058A5 JP 2016553562 A JP2016553562 A JP 2016553562A JP 2016553562 A JP2016553562 A JP 2016553562A JP 2017512058 A5 JP2017512058 A5 JP 2017512058A5
Authority
JP
Japan
Prior art keywords
fusion protein
acute
pancreatitis
lung
uti
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016553562A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017512058A (ja
JP6574431B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/017152 external-priority patent/WO2015127391A1/en
Publication of JP2017512058A publication Critical patent/JP2017512058A/ja
Publication of JP2017512058A5 publication Critical patent/JP2017512058A5/ja
Priority to JP2019109054A priority Critical patent/JP6938565B2/ja
Application granted granted Critical
Publication of JP6574431B2 publication Critical patent/JP6574431B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016553562A 2014-02-24 2015-02-23 Uti融合タンパク質 Active JP6574431B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019109054A JP6938565B2 (ja) 2014-02-24 2019-06-11 Uti融合タンパク質

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461943617P 2014-02-24 2014-02-24
US61/943,617 2014-02-24
PCT/US2015/017152 WO2015127391A1 (en) 2014-02-24 2015-02-23 Uti fusion proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019109054A Division JP6938565B2 (ja) 2014-02-24 2019-06-11 Uti融合タンパク質

Publications (3)

Publication Number Publication Date
JP2017512058A JP2017512058A (ja) 2017-05-18
JP2017512058A5 true JP2017512058A5 (enExample) 2018-04-05
JP6574431B2 JP6574431B2 (ja) 2019-09-11

Family

ID=52629709

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016553562A Active JP6574431B2 (ja) 2014-02-24 2015-02-23 Uti融合タンパク質
JP2019109054A Active JP6938565B2 (ja) 2014-02-24 2019-06-11 Uti融合タンパク質
JP2021142544A Pending JP2022002513A (ja) 2014-02-24 2021-09-01 Uti融合タンパク質
JP2023108024A Pending JP2023123763A (ja) 2014-02-24 2023-06-30 Uti融合タンパク質

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2019109054A Active JP6938565B2 (ja) 2014-02-24 2019-06-11 Uti融合タンパク質
JP2021142544A Pending JP2022002513A (ja) 2014-02-24 2021-09-01 Uti融合タンパク質
JP2023108024A Pending JP2023123763A (ja) 2014-02-24 2023-06-30 Uti融合タンパク質

Country Status (38)

Country Link
US (4) US9856310B2 (enExample)
EP (2) EP3443978A1 (enExample)
JP (4) JP6574431B2 (enExample)
KR (3) KR102722304B1 (enExample)
CN (2) CN110092837B (enExample)
AR (1) AR101597A1 (enExample)
AU (4) AU2015218704B2 (enExample)
BR (1) BR112016019390B1 (enExample)
CA (2) CA2939639C (enExample)
CL (1) CL2016002136A1 (enExample)
CR (1) CR20160444A (enExample)
CY (1) CY1120997T1 (enExample)
DK (1) DK3110434T3 (enExample)
DO (1) DOP2016000202A (enExample)
EA (2) EA037256B1 (enExample)
EC (1) ECSP16076535A (enExample)
ES (1) ES2700149T3 (enExample)
GE (1) GEP20196970B (enExample)
HR (1) HRP20182029T1 (enExample)
IL (1) IL247321B (enExample)
JO (1) JO3729B1 (enExample)
LT (1) LT3110434T (enExample)
MA (1) MA39347B2 (enExample)
MX (4) MX2016010950A (enExample)
MY (1) MY178774A (enExample)
NZ (3) NZ724196A (enExample)
PE (1) PE20170257A1 (enExample)
PH (1) PH12016501629B1 (enExample)
PL (1) PL3110434T3 (enExample)
PT (1) PT3110434T (enExample)
RS (1) RS58285B1 (enExample)
SG (2) SG11201606691QA (enExample)
SI (1) SI3110434T1 (enExample)
SM (1) SMT201800674T1 (enExample)
TW (1) TWI694084B (enExample)
UA (1) UA118866C2 (enExample)
WO (1) WO2015127391A1 (enExample)
ZA (1) ZA201606327B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016010950A (es) * 2014-02-24 2017-04-25 Takeda Gmbh Proteinas de fusion de inhibidor de tripsina urinaria (uti).
MY207281A (en) * 2017-06-07 2025-02-13 Spark Therapeutics Inc Enhancing agents for improved cell transfection and/or raav vector production
WO2020106881A1 (en) * 2018-11-20 2020-05-28 Diamedica Inc. Modified ulinastatin polypeptides
JP2021050161A (ja) 2019-09-25 2021-04-01 武田薬品工業株式会社 複素環化合物及びその用途
JP2021080177A (ja) 2019-11-14 2021-05-27 武田薬品工業株式会社 複素環化合物及びその用途
US11725043B2 (en) 2020-03-05 2023-08-15 DiaMedica USA Inc. Ulinastatin polypeptides

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663143A (en) * 1988-09-02 1997-09-02 Dyax Corp. Engineered human-derived kunitz domains that inhibit human neutrophil elastase
EP0401508B1 (de) 1989-05-13 1994-11-23 Bayer Ag Proteinaseninhibitoren, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
AU641568B2 (en) 1990-11-13 1993-09-23 Mochida Pharmaceutical Co., Ltd. Polypeptide,DNA fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same
JP2769083B2 (ja) 1993-02-22 1998-06-25 日清食品株式会社 エラスターゼ阻害活性を有する新規ペプチドおよびその製造方法
JP3469584B2 (ja) 1996-03-11 2003-11-25 バイエル コーポレイション ヒト ビクニン
DE19725014A1 (de) 1997-06-13 1998-12-17 Bayer Ag Aprotininvarianten mit verbesserten Eigenschaften und Bikunine von Aprotininvarianten
EP1730191B1 (en) * 2004-03-30 2011-07-06 Glaxo Group Limited Immunoglobulin binding hosm
KR20070041781A (ko) 2004-08-11 2007-04-19 트루비온 파마슈티칼스, 인코포레이티드 결합 도메인 융합 단백질
JP4067557B2 (ja) * 2005-06-03 2008-03-26 持田製薬株式会社 抗cd14抗体融合蛋白質
AU2006332774A1 (en) 2005-12-29 2007-07-12 Dyax Corp. Protease inhibition
WO2010035012A1 (en) * 2008-09-26 2010-04-01 Ucb Pharma S.A. Biological products
CN101721699B (zh) * 2008-10-13 2012-11-07 成都康弘生物科技有限公司 Vegf受体融合蛋白在制备治疗伴随vegf升高的炎症反应的药物中的应用
CN102580085B (zh) * 2008-10-13 2013-09-18 成都康弘生物科技有限公司 Vegf受体融合蛋白在制备治疗脓毒症药物中的应用
JP2012525847A (ja) * 2009-05-05 2012-10-25 アムジエン・インコーポレーテツド Fgf21変異体およびその使用
KR101926663B1 (ko) * 2010-02-19 2018-12-07 젠코어 인코포레이티드 신규의 CTLA4-Ig 이뮤노어드헤신
ES2666303T3 (es) * 2011-04-29 2018-05-03 University Of Washington Composiciones terapéuticas de nucleasa y métodos
US8619331B2 (en) 2011-07-19 2013-12-31 Xerox Corporation Simulated paper texture using clear toner and glossmark on texture-less stock
JP6138815B2 (ja) * 2011-12-01 2017-05-31 エーピー バイオサイエンシーズ, インコーポレイテッド 補体経路およびvegf経路に対するタンパク質インヒビターおよびそれらの使用方法
JP5855239B2 (ja) * 2012-04-23 2016-02-09 株式会社Nrlファーマ ラクトフェリン融合タンパク質及びその製造方法
CN103044554B (zh) * 2012-05-14 2014-08-27 旭华(上海)生物研发中心有限公司 重组二聚化人尿胰蛋白酶抑制剂、其制备方法及其应用
JP2013253079A (ja) * 2012-05-14 2013-12-19 Xuhua (Shanghai) Biological Research & Development Center Co Ltd 生物学的に活性なヒト尿中トリプシンインヒビターのFc融合タンパク質並びにその調製および使用
MX2016010950A (es) * 2014-02-24 2017-04-25 Takeda Gmbh Proteinas de fusion de inhibidor de tripsina urinaria (uti).

Similar Documents

Publication Publication Date Title
JP2017512058A5 (enExample)
WO2013040093A3 (en) Glucagon-like peptide-2 compositions and methods of making and using same
WO2015016761A3 (en) Mscs in the treatment of inflammatory pulmonary diseases
JP2016034981A5 (enExample)
JP2010516662A5 (enExample)
JP2016104790A5 (enExample)
WO2018053029A8 (en) Methods for treating pulmonary disease using inter-alpha inhibitor proteins
WO2017001570A3 (en) Atp-binding cassette family coding polyribonucleotides and formulations thereof
JP2015533791A5 (enExample)
JP2013529916A5 (enExample)
JP2016521566A5 (enExample)
WO2016093700A3 (en) Immunoglobulin-like molecules directed against fibronectin-eda
JP2018516239A5 (enExample)
JP2017526366A5 (enExample)
CN302544624S (zh) 卷烟(福蝠中空)
CN302537567S (zh) 卷烟(枫叶中空)
CN302537565S (zh) 卷烟(奔牛中空)
CN301582874S (zh) 木门(c21)
FANG et al. Cloning and Bioinformatic Analysis of PsACO1 gene from Furong Plum (Prunus salicina Lindl.)
CN302001526S (zh) 栏杆(同心结)
CN302016399S (zh) 保险柜(1)
CN302560901S (zh) 玩具(敲鼓拖车蛙)
CN302511420S (zh) 玩偶(心中有你1)
TH159031A (th) ไวรัสโรคหัดชนิดรีคอมบิแนนท์ที่แสดงออกถึงโพลิเพปไทด์ของไวรัสชิคุนกุนยา และการประยุกต์ใช้
CN302395281S (zh) 型材(游艇码头主龙骨结构fq-08)